详情页 - 昆明医科大学第一附属医院知识库

当前位置：首页 > 详情页

2 cases of multiple myeloma onset from coagulation disorder and literature review

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Hematology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China [2]Hematology Research Center of Yunnan Province, Kunming 650032, Yunnan, China [3]Department of Oncology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China

出处：

ISSN：

关键词： Coagulation disorder IgG type Multiple myeloma Treatment

摘要：

This article retrospectively analyzed 2 cases of multiple myeloma (MM) with onset from coagulation disorder, and reviewed the similar cases in literatures. 2 patients all exhibited skin and mucosal bleeding as the first symptom, among who one case exhibited extended prothrombin time (PT) and thrombin time, increased D-dimer quantitation, reduced clotting factor XII, while the other case exhibited extended PT and activated partial thrombo-plastin time. Both cases had no associated symptom such as pain, fever, etc., and were diagnosed as MM IgG type. Combining the retrieved similar cases, it is found that MM patients with onset from coagulation disorder all belong to IgG type, and the types of the coagulation abnormality are diverse, with no special rule. The relationship between MM and coagulation disorder are complex, and the current therapeutic strategy still mainly depends on treating the basic diseases. © 2017, E-Century Publishing Corporation. All rights reserved.

语种：

WOS：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 4 区医学

小类 | 4 区医学：研究与实验

最新[2023]版：

无

JCR分区：

出版当年[2017]版：

Q4 MEDICINE, RESEARCH & EXPERIMENTAL

最新[2023]版：

Q4 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子： 0.2 最新[2023版] 0.2 最新五年平均 0.833 出版当年[2017版] 0.926 出版当年五年平均 1.069 出版前一年[2016版] 0.181 出版后一年[2018版]

第一作者：

第一作者机构： [1]Department of Hematology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China [2]Hematology Research Center of Yunnan Province, Kunming 650032, Yunnan, China

通讯作者：

通讯机构： [1]Department of Hematology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan, China [2]Hematology Research Center of Yunnan Province, Kunming 650032, Yunnan, China [*1]Department of Hematology, First Affiliated Hospital of Kunming Medical University, No. 295 Xichang Road, Kunming 650032, Yunnan, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Analysis of RAS gene mutations in patients with multiple myeloma [2]多发性骨髓瘤的治疗进展 [3]多发性骨髓瘤骨病的发病机制 [4]Different human leukocyte antigen allele related to toxic epidermal necrolysis following lenalidomide treatment for multiple myeloma in a severely allergic family [5]Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment [6]Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma [7]Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma [8]硼替佐米治疗多发性骨髓瘤的进展 [9]Effects of triptolide on RIZ1 expression, proliferation, and apoptosis in multiple myeloma U266 cells(Open Access) [10]相关凋亡基因在多发性骨髓瘤发病中作用的研究进展